Huntington Study Group
Meet us or view our poster at this event!
The Huntington Study Group (HSG) is a Huntington disease focused boutique CRO that conducts clinical trials and provides programs that impact research and care. With a mission to seek effective treatments that improve the quality of life for people affected by Huntington disease. The annual meeting includes popular research round-up panel discussions on current clinical trials and plenary, scientific, and research sessions.
Meet Neil Matharoo, Regional Sales Manager - North America East, to discuss our ioCellsTM portfolio. He will also be presenting a poster on "Modelling neurodegeneration using a human isogenic system: A next generation approach to study Huntington’s disease". This poster will cover how the development of therapies to treat neuronal indications is hampered because of the use preclinical animal models and the lack of genetically matched controls for patient-derived models complicates the investigation of disease phenotypes. Neil will discuss how bit.bio has developed a robust iPSC reprogramming method (opti-oxTM) that overcomes these limitations and enables generation of mature cell types and isogenic disease models.
If you would like to arrange a meeting with Neil at the event please click below.
"Modelling neurodegeneration using a human isogenic system: A next generation approach to study Huntington’s disease"